Mayne Pharma Inc. received approval from the FDA for its Abbreviated New Drug Application (ANDA) for doxycycline hyclate immediate release (IR) tablets (75 mg and 150 mg). Mayne Pharma has commenced commercial launch to customers in the U.S.  Doxycycline hyclate IR tablets are a generic version of Acticlate tablets, a tetracycline-class antibacterial indicated for the treatment of a number of infections, including adjunctive therapy in severe acne. According to IMS Health, annual sales of Act...